China Acute Lymphocytic Leukemia Drug Market Report 2016

October 2016 | 118 pages | ID: C550E02263CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Acute Lymphocytic Leukemia Drug

Revenue, means the sales value of Acute Lymphocytic Leukemia Drug

This report studies sales (consumption) of Acute Lymphocytic Leukemia Drug in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• Bristol-Myers Squibb
• Novartis
• Ariad
• Arno Therapeutics
• Baxter
• Boehringer Ingelheim
• ERYTECH Pharma
• Fate Therapeutics
• Jazz Pharmaceuticals
• Orphan Europe
• Otsuka
• Ono Pharmaceuticals
• Onconova Therapeutics
• Pfizer
• Regeneron Pharmaceuticals
• Sanofi
• Sigma-Tau Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Oral
• Parenteral
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Acute Lymphocytic Leukemia Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

China Acute Lymphocytic Leukemia Drug Market Report 2016

1 ACUTE LYMPHOCYTIC LEUKEMIA DRUG OVERVIEW

1.1 Product Overview and Scope of Acute Lymphocytic Leukemia Drug
1.2 Classification of Acute Lymphocytic Leukemia Drug
  1.2.1 Oral
  1.2.2 Parenteral
  1.2.3 Type III
1.3 Application of Acute Lymphocytic Leukemia Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Acute Lymphocytic Leukemia Drug (2011-2021)
  1.4.1 China Acute Lymphocytic Leukemia Drug Sales and Growth Rate (2011-2021)
  1.4.2 China Acute Lymphocytic Leukemia Drug Revenue and Growth Rate (2011-2021)

2 CHINA ACUTE LYMPHOCYTIC LEUKEMIA DRUG COMPETITION BY MANUFACTURERS

2.1 China Acute Lymphocytic Leukemia Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 China Acute Lymphocytic Leukemia Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 China Acute Lymphocytic Leukemia Drug Average Price by Manufactures (2015 and 2016)
2.4 Acute Lymphocytic Leukemia Drug Market Competitive Situation and Trends
  2.4.1 Acute Lymphocytic Leukemia Drug Market Concentration Rate
  2.4.2 Acute Lymphocytic Leukemia Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 CHINA ACUTE LYMPHOCYTIC LEUKEMIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 China Acute Lymphocytic Leukemia Drug Sales and Market Share by Type (2011-2016)
3.2 China Acute Lymphocytic Leukemia Drug Revenue and Market Share by Type (2011-2016)
3.3 China Acute Lymphocytic Leukemia Drug Price by Type (2011-2016)
3.4 China Acute Lymphocytic Leukemia Drug Sales Growth Rate by Type (2011-2016)

4 CHINA ACUTE LYMPHOCYTIC LEUKEMIA DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 China Acute Lymphocytic Leukemia Drug Sales and Market Share by Application (2011-2016)
4.2 China Acute Lymphocytic Leukemia Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 CHINA ACUTE LYMPHOCYTIC LEUKEMIA DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Amgen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Amgen Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bristol-Myers Squibb
  5.2.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bristol-Myers Squibb Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Novartis
  5.3.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Novartis Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Ariad
  5.4.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Ariad Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Arno Therapeutics
  5.5.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Arno Therapeutics Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Baxter
  5.6.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Baxter Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Boehringer Ingelheim
  5.7.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Boehringer Ingelheim Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 ERYTECH Pharma
  5.8.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 ERYTECH Pharma Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Fate Therapeutics
  5.9.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Fate Therapeutics Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Jazz Pharmaceuticals
  5.10.2 Acute Lymphocytic Leukemia Drug Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Jazz Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Orphan Europe
5.12 Otsuka
5.13 Ono Pharmaceuticals
5.14 Onconova Therapeutics
5.15 Pfizer
5.16 Regeneron Pharmaceuticals
5.17 Sanofi
5.18 Sigma-Tau Pharmaceuticals

6 ACUTE LYMPHOCYTIC LEUKEMIA DRUG MANUFACTURING COST ANALYSIS

6.1 Acute Lymphocytic Leukemia Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Acute Lymphocytic Leukemia Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Acute Lymphocytic Leukemia Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Acute Lymphocytic Leukemia Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 CHINA ACUTE LYMPHOCYTIC LEUKEMIA DRUG MARKET FORECAST (2016-2021)

10.1 China Acute Lymphocytic Leukemia Drug Sales, Revenue Forecast (2016-2021)
10.2 China Acute Lymphocytic Leukemia Drug Sales Forecast by Type (2016-2021)
10.3 China Acute Lymphocytic Leukemia Drug Sales Forecast by Application (2016-2021)
10.4 Acute Lymphocytic Leukemia Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Acute Lymphocytic Leukemia Drug
Table Classification of Acute Lymphocytic Leukemia Drug
Figure China Sales Market Share of Acute Lymphocytic Leukemia Drug by Type in 2015
Figure Oral Picture
Figure Parenteral Picture
Table Application of Acute Lymphocytic Leukemia Drug
Figure China Sales Market Share of Acute Lymphocytic Leukemia Drug by Application in 2015
Figure China Acute Lymphocytic Leukemia Drug Sales and Growth Rate (2011-2021)
Figure China Acute Lymphocytic Leukemia Drug Revenue and Growth Rate (2011-2021)
Table China Acute Lymphocytic Leukemia Drug Sales of Key Manufacturers (2015 and 2016)
Table China Acute Lymphocytic Leukemia Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Acute Lymphocytic Leukemia Drug Sales Share by Manufacturers
Figure 2016 Acute Lymphocytic Leukemia Drug Sales Share by Manufacturers
Table China Acute Lymphocytic Leukemia Drug Revenue by Manufacturers (2015 and 2016)
Table China Acute Lymphocytic Leukemia Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Acute Lymphocytic Leukemia Drug Revenue Share by Manufacturers
Table 2016 China Acute Lymphocytic Leukemia Drug Revenue Share by Manufacturers
Table China Market Acute Lymphocytic Leukemia Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Acute Lymphocytic Leukemia Drug Average Price of Key Manufacturers in 2015
Figure Acute Lymphocytic Leukemia Drug Market Share of Top 3 Manufacturers
Figure Acute Lymphocytic Leukemia Drug Market Share of Top 5 Manufacturers
Table China Acute Lymphocytic Leukemia Drug Sales by Type (2011-2016)
Table China Acute Lymphocytic Leukemia Drug Sales Share by Type (2011-2016)
Figure China Acute Lymphocytic Leukemia Drug Sales Market Share by Type in 2015
Table China Acute Lymphocytic Leukemia Drug Revenue and Market Share by Type (2011-2016)
Table China Acute Lymphocytic Leukemia Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Acute Lymphocytic Leukemia Drug by Type (2011-2016)
Table China Acute Lymphocytic Leukemia Drug Price by Type (2011-2016)
Figure China Acute Lymphocytic Leukemia Drug Sales Growth Rate by Type (2011-2016)
Table China Acute Lymphocytic Leukemia Drug Sales by Application (2011-2016)
Table China Acute Lymphocytic Leukemia Drug Sales Market Share by Application (2011-2016)
Figure China Acute Lymphocytic Leukemia Drug Sales Market Share by Application in 2015
Table China Acute Lymphocytic Leukemia Drug Sales Growth Rate by Application (2011-2016)
Figure China Acute Lymphocytic Leukemia Drug Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Ariad Basic Information List
Table Ariad Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ariad Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Arno Therapeutics Basic Information List
Table Arno Therapeutics Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arno Therapeutics Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Baxter Basic Information List
Table Baxter Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table ERYTECH Pharma Basic Information List
Table ERYTECH Pharma Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table ERYTECH Pharma Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Fate Therapeutics Basic Information List
Table Fate Therapeutics Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fate Therapeutics Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Jazz Pharmaceuticals Basic Information List
Table Jazz Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jazz Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Orphan Europe Basic Information List
Table Orphan Europe Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orphan Europe Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Otsuka Basic Information List
Table Otsuka Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Otsuka Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Ono Pharmaceuticals Basic Information List
Table Ono Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ono Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Onconova Therapeutics Basic Information List
Table Onconova Therapeutics Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onconova Therapeutics Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Sigma-Tau Pharmaceuticals Basic Information List
Table Sigma-Tau Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sigma-Tau Pharmaceuticals Acute Lymphocytic Leukemia Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Lymphocytic Leukemia Drug
Figure Manufacturing Process Analysis of Acute Lymphocytic Leukemia Drug
Figure Acute Lymphocytic Leukemia Drug Industrial Chain Analysis
Table Raw Materials Sources of Acute Lymphocytic Leukemia Drug Major Manufacturers in 2015
Table Major Buyers of Acute Lymphocytic Leukemia Drug
Table Distributors/Traders List
Figure China Acute Lymphocytic Leukemia Drug Production and Growth Rate Forecast (2016-2021)
Figure China Acute Lymphocytic Leukemia Drug Revenue and Growth Rate Forecast (2016-2021)
Table China Acute Lymphocytic Leukemia Drug Production Forecast by Type (2016-2021)
Table China Acute Lymphocytic Leukemia Drug Consumption Forecast by Application (2016-2021)